-
1
-
-
0032784783
-
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997
-
Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J. et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3835-3849
-
-
Harris, N.L.1
Jaffe, E.S.2
Diebold, J.3
Flandrin, G.4
Muller-Hermelink, H.K.5
Vardiman, J.6
-
2
-
-
0027444652
-
The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma
-
The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
3
-
-
0035281784
-
2-(Fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial
-
Buchmann I., Reinhardt M., Elsner K., Bunjes D., Altehoefer C., Finke J. et al. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001; 91: 889-899.
-
(2001)
Cancer
, vol.91
, pp. 889-899
-
-
Buchmann, I.1
Reinhardt, M.2
Elsner, K.3
Bunjes, D.4
Altehoefer, C.5
Finke, J.6
-
5
-
-
0035074636
-
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
-
Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 2001; 86: 266-73.
-
(2001)
Haematologica
, vol.86
, pp. 266-273
-
-
Jérusalem, G.1
Béguin, Y.2
Fassotte, M.F.3
Najjar, F.4
Paulus, P.5
Rigo, P.6
-
6
-
-
0034909179
-
Effect of whole-body (18)F-FDG-PET imaging on clinical staging and management of patients with malignant lymphoma
-
Schoder H., Meta J., Yap C., Ariannejad M., Rao J., Phelps M.E. et al. Effect of whole-body (18)F-FDG-PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42: 1139-1143.
-
(2001)
J Nucl Med
, vol.42
, pp. 1139-1143
-
-
Schoder, H.1
Meta, J.2
Yap, C.3
Ariannejad, M.4
Rao, J.5
Phelps, M.E.6
-
7
-
-
0042449063
-
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
-
NCI Sponsored International Working Group
-
Cheson B.D., Horning S.J., Coiffier B., Shipp M.A., Fisher R.I., Connors J.M. et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1244
-
-
Cheson, B.D.1
Horning, S.J.2
Coiffier, B.3
Shipp, M.A.4
Fisher, R.I.5
Connors, J.M.6
-
8
-
-
0033566341
-
Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
-
Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94: 429-433.
-
(1999)
Blood
, vol.94
, pp. 429-433
-
-
Jérusalem, G.1
Béguin, Y.2
Fassotte, M.F.3
Najjar, F.4
Paulus, P.5
Rigo, P.6
-
9
-
-
0034485716
-
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
-
Mikhaeel N.G., Timothy A.R., O'Doherty M.J., Hain S., Maisey M.N. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT. Leuk Lymphoma 2000; 39: 543-553.
-
(2000)
Leuk Lymphoma
, vol.39
, pp. 543-553
-
-
Mikhaeel, N.G.1
Timothy, A.R.2
O'Doherty, M.J.3
Hain, S.4
Maisey, M.N.5
-
10
-
-
2642613656
-
Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
-
Römer W., Hanauske A.R., Ziegler S., Thodtmann R., Weber W., Fuchs C. et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 1998; 91: 4464-4471.
-
(1998)
Blood
, vol.91
, pp. 4464-4471
-
-
Römer, W.1
Hanauske, A.R.2
Ziegler, S.3
Thodtmann, R.4
Weber, W.5
Fuchs, C.6
-
11
-
-
0033624050
-
Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma
-
Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica 2000; 85: 613-618.
-
(2000)
Haematologica
, vol.85
, pp. 613-618
-
-
Jérusalem, G.1
Béguin, Y.2
Fassotte, M.F.3
Najjar, F.4
Paulus, P.5
Rigo, P.6
-
12
-
-
0036327331
-
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease
-
Kostakoglu L., Coleman M., Leonard J.P., Kuji I., Zoe H., Goldsmith S.J. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002; 43: 1018-1027.
-
(2002)
J Nucl Med
, vol.43
, pp. 1018-1027
-
-
Kostakoglu, L.1
Coleman, M.2
Leonard, J.P.3
Kuji, I.4
Zoe, H.5
Goldsmith, S.J.6
-
13
-
-
0036739436
-
Early restaging positron emission tomography with (18)F- fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
-
Spaepen K., Stroobants S., Dupont P., Vandenberghe P., Thomas J., de Groot T. et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13: 1356-1363.
-
(2002)
Ann Oncol
, vol.13
, pp. 1356-1363
-
-
Spaepen, K.1
Stroobants, S.2
Dupont, P.3
Vandenberghe, P.4
Thomas, J.5
De Groot, T.6
-
14
-
-
0037142053
-
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
-
Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-1947.
-
(2002)
N Engl J Med
, vol.346
, pp. 1937-1947
-
-
Rosenwald, A.1
Wright, G.2
Chan, W.C.3
Connors, J.M.4
Campo, E.5
Fisher, R.I.6
-
15
-
-
2342587416
-
Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes
-
Lossos I.S., Czerwinski D.K., Alizadeh A.A., Wechser M.A., Tibshirani R., Botstein D. et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350: 1828-1837
-
(2004)
N Engl J Med
, vol.350
, pp. 1828-1837
-
-
Lossos, I.S.1
Czerwinski, D.K.2
Alizadeh, A.A.3
Wechser, M.A.4
Tibshirani, R.5
Botstein, D.6
|